What a buyer sees
SIGNATURE MEDICAL LIMITED
Other human health activities · Glasgow · SC607129
86staff · FY2023
8years trading
—oldest owner on file
£1.5Mcash at bank
Your turnover is on public record
filed£16Mfor the year to 2023
Unusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.
What your filings show moving
Staff86
202121 → 862023
How you sit in your trade
slowest tenth typical fastest tenth youSales per employee£183,758in the top quarter
£29,055£51,789£189,005
Debtor daysdaysnot on your filings
122972
Creditor daysdaysnot on your filings
81339
Stock daysdaysnot on your filings
723151
Each spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 3
- The newest accounts on file are 32 months oldAnyone looking at the company today is reading a year that has already ended. Whatever has improved since is invisible.
- One director on the registerA buyer's first question about a company run by one person is what happens to it if that person stops. It is usually the first thing priced.
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 2
- Headcount grew from 51 to 86Growth a buyer can verify without asking you for anything.
- Sales per employee better than three quarters of your tradeYours is 183,758 against 51,788 for the middle of 109 comparable companies.
What the register says
Owners
Nobody recorded with significant control.
Directors
- 47since 2018
| Year to | Turnover | Staff | Cash |
|---|---|---|---|
| 2023-12-31 | £16M | 86 | £1.5M |
| 2022-12-31 | not filed | 51 | — |
| 2021-12-31 | not filed | 21 | — |
A rough bracket, and why it is only that
0.6–1.3× sales£9.5M£21M
The turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.